790304-99-3

Basic information

• Product Name: (S)-methyl 2-(tert-butoxycarbonylamino)-3-(pent-4-enyloxy)propanoate
• Synonyms: (S)-methyl 2-(tert-butoxycarbonylamino)-3-(pent-4-enyloxy)propanoate;(S)-Methyl 2-((tert-butoxycarbonyl)aMino)-3-(pent-4-en-1-yloxy)propanoate
• CAS NO: 790304-99-3
• Molecular Formula: C₁₄H₂₅NO₅
• Molecular Weight: 287.352
• Mol File: 790304-99-3.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 386.4±42.0 °C(Predicted)
• Appearance: /
• Density: 1.036±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 10.69±0.46(Predicted)
• CAS DataBase Reference: (S)-methyl 2-(tert-butoxycarbonylamino)-3-(pent-4-enyloxy)propanoate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-methyl 2-(tert-butoxycarbonylamino)-3-(pent-4-enyloxy)propanoate(790304-99-3)
• EPA Substance Registry System: (S)-methyl 2-(tert-butoxycarbonylamino)-3-(pent-4-enyloxy)propanoate(790304-99-3)

Safety Data

• Hazardous Substances Data: 790304-99-3(Hazardous Substances Data)

Usage

General Description

(S)-methyl 2-(tert-butoxycarbonylamino)-3-(pent-4-enyloxy)propanoate is a chemical compound that consists of a methyl ester group, an amino group protected by a tert-butoxycarbonyl (Boc) group, and a pent-4-enyloxy group. (S)-methyl 2-(tert-butoxycarbonylamino)-3-(pent-4-enyloxy)propanoate may be used as a building block or intermediate in organic synthesis, particularly in the preparation of pharmaceuticals or other biologically active compounds. It has the potential to undergo various chemical reactions, such as deprotection of the amino group, ester hydrolysis, and cross-coupling reactions, to yield new and diverse molecules with potentially useful properties. The specific stereochemistry and structure of this compound make it particularly interesting for use in organic and medicinal chemistry research.

Upstream product

• 3262-72-4 (S)-N-(tert-butoxycarbonyl)serine 
• 1119-51-3 bromopentene 
• 74-88-4 methyl iodide 
• 790305-00-9 (S)-2-(((tert-butoxy)carbonyl)amino)-3-(pent-4-enyloxy)propanoic acid 

Downstream Products

• 1338650-05-7 1-{[4-(4-bromobenzenesulfonyloxy)-1-(2-cyclopentyloxycarbonylamino-3-pent-4-enyloxypropionyl)pyrrolidine-2-carbonyl]amino}-2-vinylcyclopropanecarboxylic acid ethyl ester 
• 790305-00-9 (S)-2-(((tert-butoxy)carbonyl)amino)-3-(pent-4-enyloxy)propanoic acid 

Relevant articles and documents

A concise synthesis of the HCV protease inhibitor BILN 2061 and its P3 modified analogs

A concise synthesis of BILN 2061 was achieved through more efficient installation of P2 4-quinoline moiety via SN2 displacement of the β-OBs group located on the 4-hydroxyl proline intermediate, which was prepared from 4-α-hydroxyl proline analog via Mitsunobu reaction with inversion of stereochemistry. In addition, a short and practical synthesis for P3 unit is also described herein. Final assembly of four fragments for BILN 2061 was achieved with an overall yield of 58% in 4 steps from P1 to 15a. Furthermore several analogs of BILN 2061 (WX-1-WX-5) containing modifications on P3 unit were synthesized successfully using the same synthetic route as described for the parent inhibitor BILN 2061. Copyright

Inhibitors of Hepatitis C Virus

Macrocyclic peptides are disclosed having the general formula: wherein R3, R3′, R4, R6, R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Inhibitors of Hepatitis C Virus

Macrocyclic peptides are disclosed having the general formula: wherein R3, R′3, R4, R6, R′, X, Q and W are described. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.